HWGB 9601

HWGB 9601 Share Price

RM0.47

(13 customer reviews)
52 Weeks Range : 0.12 - 1.52

5 day volume Average = 3,588,340
20 day volume Average = 3,869,085
90 day volume Average = 24,987,901
Add to wishlistAdded to wishlistRemoved from wishlist 2
Add to compare
3.0/10 (Expert Score)
Product is rated as #223 in category BM Industrial Products & Services
Prospective Profit
0.882
Assets
0.400
Dividend/ Cash
2.398
Liquidity
8.469
PROS:
  • Positive Cash Company
  • Very High Trading Value
CONS:
  • Making Huge Loss
  • No Dividend Declared
  • Very Low Price-to-Tangible
  • Very High Gearing

klse: Ho Wah Genting Bhd


Corporate Information

Board   : Main

Shariah : Shariah Compliant

Sector   : Electrical Products Copper

Address: Wisma Ho Wah Genting,1st Floor, No. 35
, Jalan Maharajalela, 50150, Kuala Lumpur

Contact: +603-21438811

Website: https://www.hwgenting.com.my/
 

Corporate Background

Ho Wah Genting Berhad is an investment holding company. The Company, through its subsidiaries, manufactures wires, cables, molded power supply cord sets, and cable assemblies for electrical and electronic devices and equipment.

Genaral Info: HWGB 9601

Market Capital (RM) 278, 391, 729
Forecasted Profit or Loss (RM) -2, 460, 533
Estimated Future EPS (sen) -0.39
Perspective P/E ratio -119.364
Estimated Dividend Yield (%) 0
Adjusted NTA (RM) 0.076

Result

Quarter Report History

Date Revenue,k PBT,k Net Profit,k
24/02/21 90,527 -21,227 -20,924
26/11/20 96,092 2 -773
27/08/20 53,267 -1,699 -1,869
28/05/20 48,175 1,954 1,169
27/02/20 34,378 -5,572 -5,084
26/11/19 47,222 -379 -722
21/08/19 62,027 884 -174
30/05/19 37,343 -756 -1,010
28/02/19 38,448 1,550 -28,726
22/11/18 44,102 121 -2,106
28/08/18 37,454 614 562
30/05/18 39,703 -2,923 -2,783

Fundamental

Fundamental Analysis

Last 4 Quarter Revenue (RM’000) 288,061
Last 4 Quarter Net Profit (RM’000) -22,428
Last 4 Quarter EPS (sen) -4.51
Last 4 Quarter PER
Last 4 Quarter Dividend (sen)
Last 4 Quarter Dividend Yield (%)
Net Tangible Assets (RM) 0.07
Goodwill (RM) 0
Cash (RM’000) 20,540
Debt (RM’000) 21,690
Total Debt (RM’000) 91,530
Net Assets (RM’000) 40,500
Current Ratio 1.24
Quick Ratio 0.60
Cash Ratio 0.17

Technical

Technical Analysis

MACD (26 vs 12) -0.025
Exponential Moving Average 5 0.479
Exponential Moving Average 20 0.512
Exponential Moving Average 90 0.593
Relative Strength Index 14 0.15
Stochastic %D 3 0.12
Stochastic %K 14 0.09

13 reviews for HWGB 9601

2.1 out of 5
0
0
3
2
2
Write a review
Show all Most Helpful Highest Rating Lowest Rating
  1. Avatar

    The Edge

    Ho Wah Genting Berhad, through its wholly-owned subsidiary HWGB Biotech Sdn Bhd has been successfully granted the Pharmacist’s Poisons Licence (Type A License) from the Pharmaceutical Services Division of Ministry of Health Malaysia which enable the Company to import, store and deal generally by wholesale all controlled medicine.

    Helpful(0) Unhelpful(0)You have already voted this
  2. Avatar

    The Star

    Ho Wah Genting Bhd has obtained a full pharmaceutical product registration approval for its wholly-owned subsidiary, Astramern Sdn Bhd’s health supplement, Astramern Astra H, from the National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health. The NPRA’s full approval for the health supplement and traditional medicine is granted for the maximum period of five years and renewable thereof, it said in a statement here today.

    Helpful(0) Unhelpful(0)You have already voted this
  3. Avatar

    The Edge

    Ho Wah Genting Bhd is planning to raise up to RM34.58 million via a private placement. The group said it would be placing up to 60.67 million new shares, representing 10% of its share capital of 606.68 million shares, among third-party investors. Ho Wah Genting plans to use up to RM12 million of the placement proceeds to purchase healthcare products and for research and development activities for its healthcare-related business. Another RM10 million would be used to fully repay a loan from Hong Kong-based Prime King Investment Ltd. Up to RM11.77 million of the proceeds would be used for general working capital requirements.

    Helpful(0) Unhelpful(0)You have already voted this
  4. Avatar

    The Edge

    Ho Wah Genting Bhd’s share price declined 22% to 69 sen from 89 sen between Dec 7 and 14. Chinese national Zhang Yong, through ZY Sales & Distribution Sdn Bhd, ceased to be a substantial shareholder of HWG after disposing of his entire stake on the open market. It was only in October that Zhang emerged as a shareholder of HWG through ZY Sales & Distribution after acquiring 90 million shares or a 17.09% stake. HWG, which started the year as a penny stock trading at 11 sen, hit a high of RM1.29 on Aug 11 on speculative fervour surrounding the Covid-19 theme, but has been on a decline since.

    Helpful(0) Unhelpful(0)You have already voted this
  5. Avatar

    The Edge

    Ho Wah Genting Bhd said its wholly-owned subsidiary has obtained a one-year conditional approval from Indonesia’s health ministry to manufacture medical products such as surgical face masks, Covid-19 rapid test cassettes and liquid chemical sterilants.

    Helpful(0) Unhelpful(0)You have already voted this
  6. Avatar

    The Star

    US-based E-MO Biology Inc, the joint-venture partner of Ho Wah Genting Bhd’s wholly-owned subsidiary, HWGB Biotech Sdn Bhd, has obtained approval from the US Food and Drug Administration (FDA) to conduct phase IV clinical trials for a vaccine against Covid-19. In a statement, HWGB said HWGB Biotech would invest US$1mil (RM4.16mil) and would be entitled to 40% of the total net profit. With the FDA approval, HWGB chief executive officer Datuk Aaron Lim said the repurposing of the proven polio virus vaccines could fast track the Covid-19 vaccine development to save lives

    Helpful(0) Unhelpful(0)You have already voted this
  7. Avatar

    The Edge

    A report that Malaysia will be a priority recipient of China’s COVID-19 vaccine bodes well for the pharmaceutical counters and companies which had secured the vaccine deals. Ho Wah Genting, of which its wholly-owned subsidiary, HWGB Biotech Sdn Bhd entered into a Memorandum of Understanding (MoU) with Xinkexian (Beijing) Biotechnology Co, Ltd (XKX) last month to consider appointing XKX as its non-exclusive manufacturer to produce COVID-19 vaccines, also improved 10 sen to 74 sen.

    Helpful(0) Unhelpful(0)You have already voted this
  8. Avatar

    The Edge

    The company has been on investors’ radar screens since the coronavirus outbreak, initially over the distribution of Covid-19 test kits. However, it upped its game in August when it declared that it was officially in the race to produce a vaccine. However, there is scepticism over whether its ventures will succeed. Leinves PLT chief investment officer William Ng expresses doubts over HWGB’s plan to produce Covid-19 vaccines. He says HWGB does not have an established track record in the pharmaceutical industry

    Helpful(0) Unhelpful(0)You have already voted this
  9. Avatar

    The Edge

    HWGB’s joint venture partner, US-based E-MO Biology Inc (EBI), has entered into three research and development (R&D) agreements to produce COVID-19 vaccines.

    Helpful(0) Unhelpful(0)You have already voted this
  10. Avatar

    BURSA MALAYSIA

    The Group’s revenue for the current quarter increased by RM5.09 million or 10.6% compared to its immediate preceding quarter. The higher revenue in the current quarter was due to higher demand from existing customers.

    Helpful(0) Unhelpful(0)You have already voted this
  11. Avatar

    REMUNERATION STUDY

    In Financial Year End 2019, the directors’ remuneration was 1.34 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 21.2 million and auditor’s remuneration of 125 thousands

    Helpful(0) Unhelpful(0)You have already voted this
  12. Avatar

    BURSA MALAYSIA

    The Group’s revenue for the current quarter increased by RM13.79 million or 40.1% compared to its preceding quarter. The higher revenue was due to higher demand from existing customers. The Group recorded a PBT of RM1.95 million in the current quarter as compared to a LBT of RM5.60 million in the preceding quarter. The higher LBT was mainly due to an allowance of expected credit loss on amount due from an associate of RM4.00 million and lower profit generated from the Group’s lower revenue recorded.

    Helpful(1) Unhelpful(0)You have already voted this
  13. Avatar

    Investing Malaysia

    Average investing volume for Ho Wah Genting Bhd in the past three months in stock market was 1171.2k lots

    Helpful(0) Unhelpful(0)You have already voted this
  14. Avatar

    Investing Malaysia

    HWGB gets a score of 6.55 in our equity and assets quality test based on current share price of RM0.12

    Helpful(0) Unhelpful(0)You have already voted this
  15. Avatar

    Investing Malaysia

    Ho Wah Genting Bhd gets a score of 8.31 in our stability test after the balance sheet, money statement study

    Helpful(0) Unhelpful(0)You have already voted this
  16. Avatar

    Investing Malaysia

    Stock code of 9601 in Bursa Malaysia did not propose any dividend for the past few years

    Helpful(0) Unhelpful(0)You have already voted this
  17. Avatar

    Investing Malaysia

    HWGB is forecasted to made loss of 2.31 millions, with an adjusted market capitalization of 56.09 millions

    Helpful(0) Unhelpful(0)You have already voted this
  18. Avatar

    REMUNERATION STUDY

    In Financial Year End 2018, the directors’ remuneration was 1.57 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 19.2 million and auditor’s remuneration of 126 thousands

    Helpful(0) Unhelpful(0)You have already voted this

    Add a review

    Your email address will not be published.

    klse share price, target price, profit PER estimation
    Register New Account
    Name (required)
    Reset Password
    Compare items
    • Total (0)
    Compare